DalsnaFinance › IPOs › Mbx Biosciences Inc › IPO
MBX Biosciences, Inc. completed its initial public offering on NASDAQ on September 13, 2024, pricing at $16.00 a share.
| Ticker | MBX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 13, 2024 |
| Offering price | $16.00 |
| Shares offered | 10,200,000 |
| Total raised | $163M |
MBX Biosciences, Inc. sold 10,200,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $163.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $163 million total recorded for the deal.
MBX Biosciences, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for MBX Biosciences, Inc.. This page is general information, not investment advice.